More Good News for Novel Drug That Cuts LDL

(MedPage Today) -- More phase III results showed that Amgen's investigational PCSK9 inhibitor evolocumab significantly reduced LDL cholesterol within 12 weeks, this time in patients who were also taking a statin, the drugmaker announced. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1kfEUXH